ResearcherUniversity of MichiganNo recent work listed
Yanyan Li
Matched on ORCID iD 0009-0005-7231-9293; OpenAlex author ID A5100324150. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper
Papers 4
- NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer. First author DOI 10.1038/s41388-019-0806-6↗
- Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Co-author DOI 10.18632/oncotarget.15692↗
- Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. First author DOI 10.7314/apjcp.2014.15.15.6015↗
- Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone functi… Co-author DOI 10.1080/01635581.2011.596645↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yao Zong YUAN · 2 shared papers, 2017–2019 · strength 0.17
- Paper NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic canc… DOI 10.1038/s41388-019-0806-6↗
- Paper Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta… DOI 10.18632/oncotarget.15692↗
- Pingting Zhou · 2 shared papers, 2017–2019 · strength 0.17
- Paper NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic canc… DOI 10.1038/s41388-019-0806-6↗
- Paper Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta… DOI 10.18632/oncotarget.15692↗
- Dong Li · 1 shared paper, 2019 · strength 0.11
- Bo Li · 1 shared paper, 2019 · strength 0.11
- Fu-Rao Liu · 1 shared paper, 2017 · strength 0.07
- Bo Li · 1 shared paper, 2017 · strength 0.07
- Dong Li · 1 shared paper, 2017 · strength 0.07
- Ping Li · 1 shared paper, 2014 · strength 0.05
- Xuelei Ma · 1 shared paper, 2014 · strength 0.05
- Duxin Sun · 1 shared paper, 2011 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.